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Supplementary Table 1: Results for the simulation study of 12-month moving average
exposure with a compound symmetry covariance structure, for different intra-class corre-
lations (ρICS) and different amounts of measurement error (ρ).
Estimated βˆ(SˆE[βˆ]) Relative Bias(%) 95% CI Coverage(%)
ρICS ρ Naive Corrected Naive Corrected Naive Corrected
There is 1 measurement per validation study subject
n1 = 1000, n2 = 500, Common disease
0.3 0.4 0.321( 0.076) 0.421( 0.143) -35.7 -15.8 35.7 90.1
0.6 0.328( 0.076) 0.464( 0.128) -34.4 -7.1 37.3 95.3
0.9 0.325( 0.076) 0.475( 0.114) -35.0 -5.0 35.7 96.3
0.6 0.4 0.327( 0.058) 0.448( 0.126) -34.6 -10.4 14.5 91.5
0.6 0.326( 0.058) 0.470( 0.104) -34.7 -5.9 14.1 93.7
0.9 0.326( 0.058) 0.478( 0.088) -34.9 -4.4 16.1 94.2
0.9 0.4 0.325( 0.049) 0.459( 0.121) -34.9 -8.1 6.2 90.8
0.6 0.328( 0.049) 0.475( 0.094) -34.3 -5.1 5.8 95.2
0.9 0.328( 0.049) 0.481( 0.076) -34.5 -3.8 5.9 95.6
n1 = 50000, n2 = 500, Rare disease
0.3 0.4 0.344( 0.075) 0.446( 0.148) -31.2 -10.9 44.8 91.9
0.6 0.349( 0.075) 0.483( 0.127) -30.3 -3.3 47.9 94.3
0.9 0.347( 0.075) 0.498( 0.112) -30.7 -0.4 47.6 95.6
0.6 0.4 0.349( 0.056) 0.475( 0.133) -30.2 -5.0 21.4 94.4
0.6 0.346( 0.056) 0.489( 0.104) -30.8 -2.2 23.2 95.6
0.9 0.345( 0.056) 0.497( 0.085) -31.0 -0.5 21.8 95.1
0.9 0.4 0.348( 0.046) 0.487( 0.129) -30.4 -2.5 9.1 93.8
0.6 0.348( 0.047) 0.495( 0.095) -30.5 -1.0 8.6 96.5
0.9 0.342( 0.047) 0.494( 0.072) -31.6 -1.1 7.2 94.3
There are 5 measurements per validation study subject
n1 = 1000, n2 = 500, Common disease
0.3 0.4 0.325( 0.076) 0.457( 0.117) -34.9 -8.6 37.6 92.8
0.6 0.325( 0.076) 0.472( 0.114) -35.1 -5.6 36.3 95.1
0.9 0.332( 0.076) 0.488( 0.112) -33.7 -2.5 39.5 95.5
0.6 0.4 0.327( 0.058) 0.474( 0.094) -34.6 -5.2 15.6 95.0
0.6 0.327( 0.058) 0.479( 0.089) -34.6 -4.3 16.9 95.0
0.9 0.329( 0.058) 0.485( 0.086) -34.2 -3.0 16.1 95.7
0.9 0.4 0.325( 0.049) 0.477( 0.082) -35.0 -4.5 5.9 94.0
0.6 0.324( 0.049) 0.477( 0.076) -35.1 -4.7 4.6 94.0
0.9 0.329( 0.049) 0.484( 0.073) -34.3 -3.2 5.7 94.5
n1 = 50000, n2 = 500, Rare disease
0.3 0.4 0.344( 0.075) 0.477( 0.115) -31.2 -4.5 45.1 96.4
0.6 0.347( 0.075) 0.495( 0.111) -30.6 -1.1 46.2 95.4
0.9 0.347( 0.075) 0.500( 0.109) -30.6 0.1 46.7 95.6
0.6 0.4 0.346( 0.056) 0.492( 0.091) -30.8 -1.7 20.6 94.5
0.6 0.347( 0.056) 0.499( 0.085) -30.7 -0.2 21.6 94.2
0.9 0.348( 0.056) 0.502( 0.082) -30.5 0.4 24.0 93.1
0.9 0.4 0.346( 0.046) 0.493( 0.079) -30.9 -1.3 8.6 95.3
0.6 0.346( 0.046) 0.499( 0.072) -30.9 -0.3 8.5 95.2
0.9 0.345( 0.047) 0.499( 0.068) -31.0 -0.3 8.2 94.4
True β = 0.5, the study duration t∗ = 84, the number of simulation replications B = 1000.
In the common disease situation, the cumulative incidence was about 50% with n1 = 1000.
In the rare disease situation, the cumulative incidence was about 1% with n1 = 50000.
2
ll












CS structure ( ρICS = 0.6 , τ = 0 )


















Supplementary Figure 1: Plot for relative bias in relation to the validation study size for
CS covariance structure, β = 0.5.
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